Early Neurodevelopmental Assessment Beyond CP: Updated Evidence on Transdiagnostic and Innovative Tools (MOS‑R, HINE, BabyOSCAR) to Inform Developmental Trajectories - Ireland, 2026
About Early Neurodevelopmental Assessment Beyond CP: Updated Evidence on Transdiagnostic and Innovative Tools (MOS‑R, HINE, BabyOSCAR) to Inform Developmental Trajectories - Ireland, 2026
Join us for an international workshop on Updated Evidence on Transdiagnostic and Innovative Tools!
Cork, IrelandDownload the flyer!When: Thursday 28th MayTime: 9:00am to 5:00pmVenue: INFANT Research Centre, Paediatrci Academica Unit, 1st Floor Seahorse Unit, Cork University Hospital, Wilston, Cork.
|
About the Early Detection and HINE Workshop

This 1-day course provides an update on the latest evidence on early detection, including use of the General Movement Assessment (GMA) - Motor Optimality Score (MOS-R) and Baby OSCAR with the Hammersmith Infant Neurological Examination (HINE) for the early identification of CP and the other (non-CP) conditions. The workshop provides a refresher on theoretical/practical training in the HINE embedded within a contemporary, evidence-based approach to early neurodevelopmental screening. Participants will receive an update on the latest evidence and guidelines supporting early identification of Cerebral Palsy (CP) and other neurodevelopmental disabilities (including autism, FASD and Developmental Delay), with a strong focus on translating this evidence into clinical practice.
The Hammersmith Infant Neurological Examination (HINE) is a simple, standardised, and scoreable clinical neurological examination to identify infants with a high probability of CP, and as a transdiagnostic tool for other, non-cerebral palsy neurodevelopmental disability, including cognitive and motor delays in babies with newborn-detectable risk factors (preterm & term). Participants will explore how the GMA, MOS-R, Baby OSCAR and HINE can be effectively integrated to strengthen early risk stratification and prognosis for CP and broader neurodisability or neurodivergent outcomes such as autism, FASD, motor and cognitive delays, to guide targeted interventions.
A key theme is moving beyond diagnosis alone, using early assessment tools to inform functional trajectories, clinical decision-making, and meaningful early intervention.
Workshop Overview and Objectives
This course emphasises the use of the HINE not only for early identification of CP, but also for early prediction of functional outcomes and CP distribution, supporting earlier prognostic discussions and targeted intervention planning. Participants will learn accurate administration and scoring of the HINE through practical, small-group training using infants aged 4–24 months. The course also introduces evidence-based and emerging tools, including the General Movements Assessment, Motor Optimality Score–Revised (MOS-R), and BabyOSCAR, demonstrating how combined assessments can be used to interpret infant developmental trajectories and identify broader non-CP neurodevelopmental disability and delay. Participants will receive an updated resource booklet and access to key readings to support ongoing learning and clinical implementation.
This workshop will be delivered by Professor Roslyn Boyd PhD, MSc (PT), Professor of Cerebral Palsy Research, and Dr Carly Luke PhD, MSc (PT), Advanced GMA‑certified HINE Trainer, both internationally recognised leaders in early detection and neurodevelopmental research.
Training objectives
By the end of this workshop, participants will be able to:
- Outline the current evidence supporting the use of the Hammersmith Infant Neurological Examination (HINE) for the early identification of infants at high risk of cerebral palsy and other neurodevelopmental disabilities and delays.
- Demonstrate accurate administration of the HINE using video examples and hands-on, case-based learning in infants with neurodevelopmental risk factors.
- Apply HINE scoring in practice, including scoring infant case examples to determine risk status and interpret clinical findings.
- Use the HINE to inform clinical decision-making, including prioritising early, targeted intervention goals and integrating findings with complementary and emerging tools (such as the General Movements Assessment, Motor Optimality Score–Revised [MOS-R], and BabyOSCAR) to interpret infant developmental trajectories and support early risk stratification.
Who should attend?
Any individual interested in or currently involved in clinical practice and research for early identification and provision of early intervention for infants at high risk of cerebral palsy (including Physiotherapists, Paediatricians, Child Neurologists, Occupational Therapists). This training is suitable for any level and there are no pre-requisites
Pricing
Morning tea, lunch and afternoon tea are included in cost. Register today to avoid missing out, only 35 seats available.
| Clinicians, Allied Health Professionals | $320AUD (€200) |
| Medical Physicians | $490AUD (€300) |
| Register Now, Pay Later | Enquire Here |
*All prices are charged in AUD. GBP prices are provided as an estimate only, based on current exchange rates at the time of quoting.
If you require a flexible payment option, please contact qcprrc@uq.edu.au.
Presenters
Professor Roslyn Boyd
PhD, MSc PT Advanced GMA certified.
Professor of Cerebral Palsy Research
Dr Carly Luke
PhD, MSc PT Advanced GMA certified.
HINE Trainer

Contact
Please direct any enquiries to qcprrc@uq.edu.au & r.boyd@uq.edu.au.